| Intratumor heterogeneity and branched evolution revealed by multiregion sequencing M Gerlinger, AJ Rowan, S Horswell, J Larkin, D Endesfelder, E Gronroos, ... New England journal of medicine 366 (10), 883-892, 2012 | 8610 | 2012 |
| An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients B Györffy, A Lanczky, AC Eklund, C Denkert, J Budczies, Q Li, Z Szallasi Breast cancer research and treatment 123, 725-731, 2010 | 2875 | 2010 |
| The MicroArray Quality Control (MAQC) project shows inter-and intraplatform reproducibility of gene expression measurements. L Shi, LH Reid, WD Jones, R Shippy, JA Warrington, SC Baker, PJ Collins, ... Nature biotechnology 24 (9), 1151-1161, 2006 | 2415 | 2006 |
| Tracking the evolution of non–small-cell lung cancer M Jamal-Hanjani, GA Wilson, N McGranahan, NJ Birkbak, TBK Watkins, ... New England Journal of Medicine 376 (22), 2109-2121, 2017 | 2209 | 2017 |
| Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution C Abbosh, NJ Birkbak, GA Wilson, M Jamal-Hanjani, T Constantin, ... Nature 545 (7655), 446-451, 2017 | 1730 | 2017 |
| A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers SL Carter, AC Eklund, IS Kohane, LN Harris, Z Szallasi Nature genetics 38 (9), 1043-1048, 2006 | 1289 | 2006 |
| Robustness of cellular functions J Stelling, U Sauer, Z Szallasi, FJ Doyle, J Doyle Cell 118 (6), 675-685, 2004 | 1273 | 2004 |
| Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer DP Silver, AL Richardson, AC Eklund, ZC Wang, Z Szallasi, Q Li, N Juul, ... Journal of clinical oncology 28 (7), 1145, 2010 | 1258 | 2010 |
| Spatial and temporal diversity in genomic instability processes defines lung cancer evolution EC De Bruin, N McGranahan, R Mitter, M Salm, DC Wedge, L Yates, ... Science 346 (6206), 251-256, 2014 | 1252 | 2014 |
| Homologous recombination deficiency (HRD) score predicts response to platinum-containing neoadjuvant chemotherapy in patients with triple-negative breast cancer ML Telli, KM Timms, J Reid, B Hennessy, GB Mills, KC Jensen, Z Szallasi, ... Clinical cancer research 22 (15), 3764-3773, 2016 | 909 | 2016 |
| Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. B Győrffy, A Lánczky, Z Szállási Endocrine-related cancer 19 (2), 197-208, 2012 | 862 | 2012 |
| Reliability and reproducibility issues in DNA microarray measurements S Draghici, P Khatri, AC Eklund, Z Szallasi TRENDS in Genetics 22 (2), 101-109, 2006 | 780 | 2006 |
| Neoantigen-directed immune escape in lung cancer evolution R Rosenthal, EL Cadieux, R Salgado, MA Bakir, DA Moore, CT Hiley, ... Nature 567 (7749), 479-485, 2019 | 743 | 2019 |
| Clonal status of actionable driver events and the timing of mutational processes in cancer evolution N McGranahan, F Favero, EC De Bruin, NJ Birkbak, Z Szallasi, ... Science translational medicine 7 (283), 283ra54-283ra54, 2015 | 715 | 2015 |
| Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data F Favero, T Joshi, AM Marquard, NJ Birkbak, M Krzystanek, Q Li, ... Annals of Oncology 26 (1), 64-70, 2015 | 689 | 2015 |
| Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents NJ Birkbak, ZC Wang, JY Kim, AC Eklund, Q Li, R Tian, C Bowman-Colin, ... Cancer discovery 2 (4), 366-375, 2012 | 555 | 2012 |
| Deterministic evolutionary trajectories influence primary tumor growth: TRACERx renal S Turajlic, H Xu, K Litchfield, A Rowan, S Horswell, T Chambers, ... Cell 173 (3), 595-610. e11, 2018 | 554 | 2018 |
| Chromosomal instability confers intrinsic multidrug resistance AJX Lee, D Endesfelder, AJ Rowan, A Walther, NJ Birkbak, PA Futreal, ... Cancer research 71 (5), 1858-1870, 2011 | 519 | 2011 |
| Ca (2+)-dependent and Ca (2+)-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. Reconstitution of secretory … K Ozawa, Z Szallasi, MG Kazanietz, PM Blumberg, H Mischak, ... Journal of Biological Chemistry 268 (3), 1749-1756, 1993 | 476 | 1993 |
| Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx renal TJ Mitchell, S Turajlic, A Rowan, D Nicol, JHR Farmery, T O’Brien, ... Cell 173 (3), 611-623. e17, 2018 | 475 | 2018 |
Aron Charles EklundClinical Microbiomics A/S在 clinical-microbiomics.com 的电子邮件经过验证
